Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

Anouchka Seesaghur,Majid Riaz,Matthew Thompson,Joshua Warden,Ali Abbasi,Bethany Levick,Sue Cheeseman,Peter Mcmahon,Peter Egger

doi:10.1136/bmjopen-2022-069214

Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

Anouchka Seesaghur, Majid Riaz + Show 7 more

Open Access

https://doi.org/10.1136/bmjopen-2022-069214

Copy DOI

Journal: BMJ open	Publication Date: May 1, 2023
Citations: 3	License type: open-access

Affiliation: Amgen (United Kingdom), IQVIA (United Kingdom), Leeds Teaching Hospitals NHS Trust

#Bone-targeting Agents #Breast Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveTo assess use of bone-targeting agents (BTA) in patients with confirmed bone metastases (BM) from breast cancer (BC), non-small cell lung cancer (NSCLC) or prostate cancer (PC).DesignRetrospective cohort study.SettingRegional hospital-based...

Full Text